Brokers Issue Forecasts for Medicus Pharma FY2025 Earnings

Medicus Pharma Ltd. (NASDAQ:MDCX) – Equities researchers at Brookline Capital Management boosted their FY2025 earnings per share estimates for Medicus Pharma in a research report issued on Tuesday, April 8th. Brookline Capital Management analyst K. Raja now forecasts that the company will earn ($0.88) per share for the year, up from their prior estimate of ($1.53). Brookline Capital Management has a “Strong-Buy” rating on the stock. The consensus estimate for Medicus Pharma’s current full-year earnings is ($1.14) per share. Brookline Capital Management also issued estimates for Medicus Pharma’s FY2026 earnings at ($0.86) EPS, FY2027 earnings at ($0.65) EPS and FY2028 earnings at $0.44 EPS.

Separately, Maxim Group assumed coverage on shares of Medicus Pharma in a research note on Tuesday, December 17th. They issued a “buy” rating and a $10.00 price objective for the company.

Medicus Pharma Price Performance

MDCX opened at $3.58 on Friday. Medicus Pharma has a 1-year low of $1.80 and a 1-year high of $6.00. The stock has a 50 day moving average price of $3.44.

Medicus Pharma (NASDAQ:MDCX) last announced its earnings results on Friday, March 28th. The company reported ($0.18) EPS for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.14.

Hedge Funds Weigh In On Medicus Pharma

An institutional investor recently bought a new position in Medicus Pharma stock. Interchange Capital Partners LLC purchased a new position in shares of Medicus Pharma Ltd. (NASDAQ:MDCX) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,457,165 shares of the company’s stock, valued at approximately $3,628,000. Medicus Pharma accounts for about 1.3% of Interchange Capital Partners LLC’s portfolio, making the stock its 15th biggest holding. Interchange Capital Partners LLC owned about 13.43% of Medicus Pharma at the end of the most recent reporting period.

Medicus Pharma Company Profile

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.